Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Vladimír, Džavík"'
Autor:
Eero Anttonen, MD, Olli Punkka, MD, Joonas Leivo, MD, Sanjit S. Jolly, MD, Vladimír Džavík, MD, Jyri Koivumäki, MD, Minna Tahvanainen, MD, Kimmo Koivula, MD, Kjell Nikus, MD, Jia Wang, MSc, John A. Cairns, MD, Kari Niemelä, MD, Markku Eskola, MD
Publikováno v:
CJC Open, Vol 3, Iss 10, Pp 1221-1229 (2021)
Background: We aimed to determine the association of atrial fibrillation (AF) with 1-year outcome in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). Methods: Patients (n = 8830) enrolle
Externí odkaz:
https://doaj.org/article/3a815da1e20649e19c072075b8f54ca8
Autor:
Rodolfo V. Rocha, Xuesong Wang, Stephen E. Fremes, Derrick Y. Tam, Dennis T. Ko, Vladimír Džavík, Edward L. Hannan, Peter C. Austin, Maral Ouzounian, Douglas S. Lee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 5 (2022)
Background The degree of hospital‐level variation in the ratio of percutaneous coronary interventions to coronary artery bypass grafting procedures (PCI:CABG) and the association of the PCI:CABG ratio with clinical outcome are unknown. Methods and
Externí odkaz:
https://doaj.org/article/775e1c483d8e45b49ef58c25f713ab68
Autor:
Mohammad Alkhalil, Michał Kuzemczak, Nicholas Whitehead, Charalampos Kavvouras, Vladimír Džavík
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 5 (2021)
Background Polyvascular atherosclerotic disease is associated with an increased risk of future cardiovascular events. Intensive lipid‐lowering therapy (ILT) may mitigate this risk. The aims of this study‐level meta‐analysis were to examine the
Externí odkaz:
https://doaj.org/article/2f861241360e4163abf272d159a60389
Publikováno v:
BMJ Open Quality, Vol 9, Iss 2 (2020)
Background The Summary Hospital-level Mortality Indicator (SHMI) for Myocardial Infarction (MI) is the ratio of the observed to the expected number of deaths due to MI. We aimed to assess (1) the accuracy of MI as a diagnosis in the SHMI for MI and (
Externí odkaz:
https://doaj.org/article/7ab77b7bd2e54dca9f82689a28ea2a71
Autor:
Maria Virginia Manzi, Sergio Buccheri, Sanjit S. Jolly, Felix Zijlstra, Ole Frøbert, Bo Lagerqvist, Karim D. Mahmoud, Vladimír Džavík, Emanuele Barbato, Giovanna Sarno, Stefan James
Publikováno v:
Manzi, M V, Buccheri, S, Jolly, S S, Zijlstra, F, Frøbert, O, Lagerqvist, B, Mahmoud, K D, Džavík, V, Barbato, E, Sarno, G & James, S 2022, ' Sex-Related Differences in Thrombus Burden in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention ', JACC: Cardiovascular Interventions, vol. 15, no. 20, pp. 2066-2076 . https://doi.org/10.1016/j.jcin.2022.08.013
JACC: Cardiovascular Interventions, 15(20), 2066-2076. Elsevier Inc.
JACC: Cardiovascular Interventions, 15(20), 2066-2076. Elsevier Inc.
Background: Women have a worse prognosis after ST-segment elevation myocardial infarction (STEMI) than men. The prognostic role of thrombus burden (TB) in influencing the sex-related differences in clinical outcomes after STEMI has not been clearly i
Autor:
Philippe Généreux, Gil Chernin, Abid R. Assali, Jan Z. Peruga, Simon D. Robinson, Erick Schampaert, Rodrigo Bagur, Samer Mansour, Josep Rodés-Cabau, Margaret McEntegart, Robert Gerber, Philippe L'Allier, Ranil de Silva, Benoit Daneault, Suneil K. Aggarwal, Vladimír Džavík, M. Ozgu Ozan, Ori Ben-Yehuda, Akiko Maehara, Gregg W. Stone, Michael Jonas
Publikováno v:
American Heart Journal. 249:45-56
Diabetes mellitus (DM) is an important predictor of neointimal hyperplasia (NIH) and adverse clinical outcomes after percutaneous coronary intervention (PCI). LABR-312, a novel intravenous formulation of liposomal alendronate, has been shown in anima
Autor:
Sharon Chih, Aun Yeong Chong, Vladimír Džavík, Derek Y. So, Natasha Aleksova, George A. Wells, Jordan Bernick, Christopher B. Overgaard, Ellamae Stadnick, Lisa M. Mielniczuk, Rob S.B. Beanlands, Heather J. Ross
Publikováno v:
Circulation: Heart Failure.
BACKGROUND: Early cardiac allograft vasculopathy (CAV) prognostication is needed to improve long-term outcomes after heart transplantation. We characterized first year posttransplant coronary anatomic-physiologic alterations to determine predictors o
Publikováno v:
Current Cardiology Reports. 24:277-293
The evidence for use of dual antiplatelet therapy (DAPT) for patients undergoing percutaneous coronary intervention (PCI) in the elective setting is relatively sparse and is based on data from more than two decades ago. We will review the evidence su
Autor:
Mauro Chiarito, Usman Baber, Davide Cao, Samin K. Sharma, George Dangas, Dominick J. Angiolillo, Carlo Briguori, David J. Cohen, Dariusz Dudek, Vladimír Džavík, Javier Escaned, Robert Gil, Christian W. Hamm, Timothy Henry, Kurt Huber, Adnan Kastrati, Upendra Kaul, Ran Kornowski, Mitchell Krucoff, Vijay Kunadian, Shamir R. Mehta, David Moliterno, E. Magnus Ohman, Keith Oldroyd, Gennaro Sardella, Zhang Zhongjie, Samantha Sartori, Giulio Stefanini, Richard Shlofmitz, P. Gabriel Steg, Giora Weisz, Bernhard Witzenbichler, Ya-ling Han, Stuart Pocock, C. Michael Gibson, Roxana Mehran
Publikováno v:
JACC: Cardiovascular Interventions. 15:282-293
Autor:
Jeffrey L. Carson, Maria Mori Brooks, Bernard R. Chaitman, John H. Alexander, Shaun G. Goodman, Marnie Bertolet, J. Dawn Abbott, Howard A. Cooper, Sunil V. Rao, Darrell J. Triulzi, Dean A. Fergusson, William J. Kostis, Helaine Noveck, Tabassome Simon, Philippe Gabriel Steg, Andrew P. DeFilippis, Andrew M. Goldsweig, Renato D. Lopes, Harvey White, Caroline Alsweiler, Erin Morton, Paul C. Hébert, Shahab Ghafghazi, Frances Wood, Mark Menegus, Barry Uretsky, Srikanth Vallurupalli, Gregory Maniatis, Luis Gruberg, Robert Roswell, Joseph Rossi, Farhad Abtahian, Meechai Tessalee, Gregory Barsness, Herbert Aronow, Kodangudi Ramanathan, Mark Schmidhofer, Friederike Keating, Michael Carson, Michael Kontos, Mansoor Qureshi, Stacey Clegg, Warren Laskey, Tamar Polonsky, Rajesh Gupta, Mujeeb Abdul Sheikh, Lynne Uhl, Paul Mullen, Arthur Bracey, William Matthai, Christopher Stowell, David Dudzinski, Gregary Marhefka, Perry Weinstock, William Lawson, Norma Keller, Eugene Yuriditsky, Michael Thomas, Alice Jacobs, Claudia Hochberg, Omar Siddiqi, Joshua Schulman-Marcus, Mikhail Torosoff, Michael Gitter, Xuming Dai, Jay Traverse, Eric McCamant, Jason Scott, Rajesh Swaminathan, Sunil Rao, Adam Salisbury, David Landers, Ganesh Raveendran, Ramin Ebrahimi, Richard Bach, Joseph Delehanty, Raj C. Shah, Sorin Brener, Jonathan Doroshow, Adriano Caixeta, Dalton Precoma, Frederico Toledo Campo Dall'Orto, Pedro Beraldo De Andrade, Marianna Dracoulakis, Lília Nigro Maia, Luiz Eduardo Fontelles Ritt, Alexandre Quadros, Dário Celestino Sobral Filho, Fernando De Martino, Thao Huynh, Greg Schnell, Manohara Senaratne, Vikas Tandon, John Neary, David Laflamme, Jean-Pierre Dery, Kevin Bainey, Richard Haichin, Payam Dehghani, Ata Ur Rehman Quraishi, Brian J. Potter, François Martin Carrier, Michael Goldfarb, Christopher Fordyce, Ying Tung Sia, Benoit Daneault, Mina Madan, Terry McPherson, John Ducas, Kunal Minhas, Neil Brass, Akshay Bagai, Simon Robinson, Vladimír Džavík, Razi Khan, Nicolas Michaud, Gabriel Steg, Gregory Ducrocq, Etienne Puymirat, Gilles Lemesle, Emile Ferrari, Benoit Lattuca, Johanne Silvain, Gérald Vanzetto, Laura Cetran, Thibault Lhermusier, Yves Cottin, Yann Rosamel, Denis Angoulvant, Jean Guillaume Dillinger, Christophe Thuaire, Batric Popovic, Eric Durand, Claire Bouleti, François Roubille, Laurent Delorme, Ian Crozier, Jocelyne Benatar, Samraj Nandra, Ian Ternouth, Nick Fisher, David Brieger, Graham Hillis
Publikováno v:
American heart journal.
Accumulating evidence from clinical trials suggests that a lower (restrictive) hemoglobin threshold (8% g/dL) for red blood cell (RBC) transfusion, compared with a higher (liberal) threshold (≥10 g/dL) is safe. However, in anemic patients with acut